Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Sponge on a String Could Replace Endoscopy

By LabMedica International staff writers
Posted on 24 Nov 2014
A sponge on a string that is easily swallowed could replace traditional endoscopy as an equally effective but less invasive way of diagnosing a condition that can be a forerunner of esophageal cancer.

Barrett's esophagus is usually diagnosed by having a biopsy during an endoscopy but this can be uncomfortable and carries some risks and it is not always practical for everyone who has symptoms like reflux and heartburn. More...


Scientists based at the Medical Research Council Cancer Unit (University of Cambridge, UK) invited more than 600 patients with Barrett's esophagus, a condition that can sometimes lead to esophageal cancer, to swallow the sponge and to undergo an endoscopy. Approximately 500 more people with symptoms like reflux and persistent heartburn did the same tests.

Over time people with these symptoms may develop changes in the cells that line the esophagus. These cells can become cancerous and so patients with Barrett's Esophagus are tested every couple of years.

The scientists found that the Cytosponge proved to be a very accurate way of diagnosing Barrett's esophagus. More than 94% of people swallowed the sponge and reported no serious side effects. Patients who were not sedated for endoscopy were more likely to rate the Cytosponge as a preferable experience. Esophageal cancer is the thirteenth most common cancer in the UK. Around 5,600 men develop the disease each year compared with 2,750 women. And each year around 5,200 men and 2,460 women die from the disease.

Rebecca Fitzgerald, MD, a professor and lead author of study said, “The Cytosponge test is safe, acceptable and has very good accuracy for diagnosing Barrett's esophagus. It should be considered as an alternative to endoscopy for diagnosing the condition and could possibly be used as a screening test in primary care. Julie Sharp, PhD, head of health information for Cancer Research UK, (London, UK) added, “These results are very encouraging and it will be good news if such a simple and cheap test can replace endoscopy for Barrett's esophagus. Death rates are unacceptably high in esophageal cancer so early diagnosis is vital.” The study was presented on November 4, 2014, at the National Cancer Research Institute's annual conference held in Liverpool (UK).

Related Links:

Medical Research Council Cancer Unit 
Cancer Research UK 



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
Automated Urinalysis Solution
UN-9000
New
Slide Scanner System
NanoZoomer S540MD
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Researchers from the Department of Chemistry at Aarhus University have developed and tested a new technology that can identify and measure the concentration of pharmaceuticals in under 10 minutes. Today, this process takes up to an hour. That is critical waiting time for patients suffering from a stroke. (Image Credit: Aarhus University)

Point-of-Care Blood Test Could Speed Treatment Decisions in Acute Stroke

Minutes can shape treatment decisions in emergency stroke care, particularly when physicians need to know whether a patient is taking anticoagulants before administering clot-dissolving therapy.... Read more

Microbiology

view channel
Image: The clearance also broadens QIAstat-Dx\'s infectious disease testing menu in the U.S., which already includes panels for respiratory and gastrointestinal infections, as well as meningitis and encephalitis (Photo courtesy of Qiagen)

One-Hour Molecular Panel Expands Bloodstream Infection Testing for Gram-Negative Pathogens

Bloodstream infections can progress rapidly and lead to sepsis, organ failure, and death. In the United States, about 1.7 million adults develop sepsis each year, and at least 350,000 die during hospitalization... Read more

Industry

view channel
Image

Collaboration Combines AI Cognitive Assessment and RNA Blood Testing for Earlier Alzheimer’s Detection

Alzheimer’s disease is often identified only after substantial neurodegeneration, partly because current diagnostic pathways are fragmented and difficult to scale. As treatment shifts toward earlier intervention,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.